000 01648 a2200469 4500
005 20250516225319.0
264 0 _c20150824
008 201508s 0 0 eng d
022 _a1569-8041
024 7 _a10.1093/annonc/mdu225
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aCuzick, J
245 0 0 _aEstimates of benefits and harms of prophylactic use of aspirin in the general population.
_h[electronic resource]
260 _bAnnals of oncology : official journal of the European Society for Medical Oncology
_cJan 2015
300 _a47-57 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Review
650 0 4 _aAnti-Inflammatory Agents, Non-Steroidal
_xadverse effects
650 0 4 _aAspirin
_xadverse effects
650 0 4 _aFemale
650 0 4 _aGastrointestinal Hemorrhage
_xchemically induced
650 0 4 _aHumans
650 0 4 _aMale
650 0 4 _aMyocardial Infarction
_xprevention & control
650 0 4 _aNeoplasms
_xprevention & control
650 0 4 _aStroke
_xprevention & control
700 1 _aThorat, M A
700 1 _aBosetti, C
700 1 _aBrown, P H
700 1 _aBurn, J
700 1 _aCook, N R
700 1 _aFord, L G
700 1 _aJacobs, E J
700 1 _aJankowski, J A
700 1 _aLa Vecchia, C
700 1 _aLaw, M
700 1 _aMeyskens, F
700 1 _aRothwell, P M
700 1 _aSenn, H J
700 1 _aUmar, A
773 0 _tAnnals of oncology : official journal of the European Society for Medical Oncology
_gvol. 26
_gno. 1
_gp. 47-57
856 4 0 _uhttps://doi.org/10.1093/annonc/mdu225
_zAvailable from publisher's website
999 _c24073500
_d24073500